Ibuprofen To Be Tested In The Treatment Of Patients With COVID-19

Ibuprofen to be tested in the treatment of patients with COVID-19

Doctors at London's Guy's and St Thomas' hospital and King's College believe that the drug, which is an anti-inflammatory and pain reliever, can solve breathing problems.

Photo: pixabay.com

In a randomized trial called Liberate, half of inpatients will receive ibuprofen in addition to standard therapy. It is assumed that at least 230 volunteers will participate in the experiment. Earlier, animal studies have shown that ibuprofen can treat acute respiratory distress syndrome, one of the complications of severe coronavirus, the BBC reported.

Doctors note that the study will use not the usual ibuprofen tablets, which are sold in the pharmacy, but a special dosage formula that is used in the form of lipid capsules for arthritis.

At the beginning of the pandemic, doctors were concerned that ibuprofen might not be safe for patients with mild COVID-19. Fears were heightened by a tweet from French Health Minister Oliver Veran that taking non-steroidal anti-inflammatory drugs such as ibuprofen could worsen the infection and recommended paracetamol. However, later, the Commission on Human Medicines concluded that ibuprofen, like paracetamol, is safe for the symptoms of coronavirus. She these drugs can lower the temperature and relieve the patient's condition.

However, the United Kingdom National Health Service recommends taking paracetamol first if you experience mild symptoms of coronavirus (fever, weakness, aches) because it has fewer side effects and is safer for most people. In particular, ibuprofen is contraindicated for people with stomach ulcers.